Release of C+ Centrifuge Addition for Fully Automated Sample Preparation Clarification
SOTAX has launched the C+, an automated centrifuge module for clarification of samples during fully automated sample preparations.
SOTAX has launched the C+, an automated centrifuge module for clarification of samples during fully automated sample preparations.
Agreement gives SOTAX distribution rights to Waters ACQUITY UPLC H-Class System within Small Molecule Pharmaceutical Accounts.
The 21st Century Cures Act, enacted into law December of 2016, is an initiative to expedite and enhance the process of discovery, development, and delivery for disease treatments.
We all know pharmaceutical products are only as good as the people involved in making them. How a company educates its people is vital to the overall company success. Of major concern to the pharmaceutical industry is that many companies still resort to traditional (in some cases, tick-box) training methods – rather than educating staff at all levels for lasting improvement.
NSF International will be exhibiting at Making Pharmaceuticals, the only dedicated free to attend event in the UK that addresses the detailed and complex issues associated with sourcing, manufacturing, outsourcing and delivering of consistent pharmaceutical products to the market.
SHL Group is proud to announce that it will participate in the Taiwan Pharmapack Symposium held in Taipei on March 30, 2017.
The CEO of Biovian, Knut Ringborn is available for 1-to-1 partnering at the BioEurope Spring Conference. The BioEurope Spring: March
Since stability is a great concern in the industry because pharmaceuticals must be safe and effective, on April 27th we
IT experts of TÜV Süd, a German industrial testing organization, have certified the new data processing center at Vetter's headquarters in Ravensburg, Germany. The pharmaceutical service provider has fulfilled all requirements to meet the "TÜV Süd certified data processing center" criteria.
Vetter, a leading international contract development and manufacturing organization (CDMO) that specializes in aseptic filling for its (bio-)pharmaceutical customers, has announced today that its new clinical syringe line has already manufactured for its customers a double digit number of batches for use in early clinical trials.